Lang Bragman Femiclear

FEMICLEAR is a specially formulated probiotic supplement with well-researched probiotic strains from Canada and whole cranberry extract from France.

About Lactobacillus rhamnosus R0011 and Lactobacillus helveticus R0052:

• Ability to survive gastrointestinal transit [1]
• Able to adhere to intestinal cell lines [2]
• Preserving gut health [3]

Highlights

• Microencapsulated and Lyophilized (freeze-dried) technology
• GMP-Certified
• For a healthy urinary tract

Ingredients

• L. rhamnosus ROSELL-11 (1.9 billion CFU) – strain from Canada
• L. helveticus ROSELL-52 (0.1 billion CFU)
• CranMax Cranberries – imported from France

Direction of Use

• Take 2 sachets once daily with a meal.
• The content can be consumed directly or mixed with water

This supplement is suitable for adults and children above 4 years old.

Warnings

Not recommended for people taking warfarin medication. Consult your physician if you are pregnant, nursing, taking medication, or have a medical condition.

FAQs

1. Can a man consume FEMICLEAR?

It’s safe to be consumed by both genders.

2. What are Proanthocyanidins (PAC)?

Proanthocyanidins (PAC) are a class of polyphenols found in a variety of plants and are also known as condensed tannins. They are antioxidants that can remove harmful free oxygen radicals from cells.

3. Is this supplement safe for pregnant or nursing women?

Pregnant women should avoid this product during the first trimester If you are taking other medications, please consult your healthcare providers.

4. Any added milk, eggs, soy, tree nuts, peanuts, sugar, artificial flavors, and preservatives? 

The flavor comes from cranberry extract.

5. Is this product GMO-Free, Gluten-Free, GMP-Certified, and Lab-Tested?

This product is GMO-free, gluten-free, GMP-certified, and COA-compliant.

6. Is this product suitable for vegetarians and vegans?

Yes.

7. Can I take this supplement with other medications or supplements?

References

1. Firmesse, O., Mogenet, A., Bresson, J. L., Corthier, G., & Furet, J. P. (2007, October 24). Lactobacillus rhamnosus R11 Consumed in a Food Supplement Survived Human Digestive Transit without Modifying Microbiota Equilibrium as Assessed by Real-Time Polymerase Chain Reaction. Microbial Physiology, 14(1–3), 90–99. https://doi.org/10.1159/000106087

2. Sherman, P. M., Johnson-Henry, K. C., Yeung, H. P., Ngo, P. S. C., Goulet, J., & Tompkins, T. A. (2005, August). Probiotics Reduce Enterohemorrhagic Escherichia coli O157:H7- and Enteropathogenic E. coli O127:H6-Induced Changes in Polarized T84 Epithelial Cell Monolayers by Reducing Bacterial Adhesion and Cytoskeletal Rearrangements. Infection and Immunity, 73(8), 5183–5188. https://doi.org/10.1128/iai.73.8.5183-5188.2005

3.  Foster, L., Tompkins, T., & Dahl, W. (2011, December 1). A comprehensive post-market review of studies on a probiotic product containing Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011. Beneficial Microbes, 2(4), 319–334. https://doi.org/10.3920/bm2011.0032